Clinical trial
Two Dose Neuraxial Morphine for Prevention of Postdural Puncture Headache
NCT02473276 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Two Dose Neuraxial Morphine for Prevention of Postdural Puncture Headache
- Lead sponsor
- Columbia University
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- September 30, 2015
- Completion date
- January 31, 2020
- Enrollment
- 44 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
postdural puncture headache